Literature DB >> 28324975

Quantification of peripheral and central blood pressure variability using a time-frequency method.

Z Kouchaki, M Butlin, A Qasem, A P Avolio.   

Abstract

Systolic blood pressure variability (BPV) is associated with cardiovascular events. As the beat-to-beat variation of blood pressure is due to interaction of several cardiovascular control systems operating with different response times, assessment of BPV by spectral analysis using the continuous measurement of arterial pressure in the finger is used to differentiate the contribution of these systems in regulating blood pressure. However, as baroreceptors are centrally located, this study considered applying a continuous aortic pressure signal estimated noninvasively from finger pressure for assessment of systolic BPV by a time-frequency method using Short Time Fourier Transform (STFT). The average ratio of low frequency and high frequency power band (LFPB/HFPB) was computed by time-frequency decomposition of peripheral systolic pressure (pSBP) and derived central aortic systolic blood pressure (cSBP) in 30 healthy subjects (25-62 years) as a marker of balance between cardiovascular control systems contributing in low and high frequency blood pressure variability. The results showed that the BPV assessed from finger pressure (pBPV) overestimated the BPV values compared to that assessed from central aortic pressure (cBPV) for identical cardiac cycles (P<;0.001), with the overestimation being greater at higher power.

Entities:  

Mesh:

Year:  2016        PMID: 28324975     DOI: 10.1109/EMBC.2016.7591346

Source DB:  PubMed          Journal:  Conf Proc IEEE Eng Med Biol Soc        ISSN: 1557-170X


  1 in total

1.  Autonomic and Vascular Control in Prehypertensive Subjects with a Family History of Arterial Hypertension.

Authors:  Josária Ferraz Amaral; Diana de Medeiros Andrade Borsato; Isabelle Magalhães Guedes Freitas; Edgar Toschi-Dias; Daniel Godoy Martinez; Mateus Camaroti Laterza
Journal:  Arq Bras Cardiol       Date:  2018-02-19       Impact factor: 2.000

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.